Riccardo Panella

Riccardo Panella, Ph.D., is an Associate Professor at the Center for RNA Medicine in the Copenhagen campus of Aalborg University, Denmark. He obtained his Ph.D. in Molecular Oncology in 2013 at the University of Perugia in Italy after which he was awarded a post-doctoral fellowship from the Marie Curie Foundation in 2014. He worked for six years as a Post-Doctoral fellow at Beth Israel Deaconess Medical Center Cancer Institute / Harvard Medical School Cancer Center. Riccardo Panella has focused his entire career on translational medicine, with the main goal of developing new treatment options and new therapeutic approaches to disease. His expertise lies in the application of non-coding RNA as both a therapeutic target and as cutting-edge technology for developing new therapeutic paradigms. In the laboratory, his team is currently investigating the role of non-coding RNAs in metabolic homeostasis and how it affects human metabolism. Specifically, they are striving to understand non-coding RNAs metabolic functions in cancer and other metabolically relevant diseases in order to disentangle the mechanistic relationships between microRNAs, metabolism, and cancer progression, particularly in advanced and metastatic tumors. These studies include investigations of the roles of non-coding RNA in multiple types of cancer, including, but not limited to: breast cancer, leukemia, lung cancer, and liver cancer